In summary, the overexpression of FOXK2 can enhance FAO metabolism in tumor cells through mechanisms that can be outlined as follows: it increases the binding affinity of FOXK2 to the mTOR, upregulates the expression of DRP1, and promotes FAO, thereby driving tumor progression. Here, MTOR is linked to neoplasm.